Mannkind Corp [NASDAQ: MNKD] closed the trading session at $4.63. The company report on March 26, 2024 at 4:05 PM that MannKind Announces CFO Transition. Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through December
Mannkind Corp [NASDAQ: MNKD] slipped around -0.66 points on Monday, while shares priced at $4.61 at the close of the session, down -12.52%. The company report on March 11, 2024 at 6:05 AM that INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple
Mannkind Corp [NASDAQ: MNKD] surged by $0.15 during the normal trading session on while it closed the day at $4.65. The company report on March 4, 2024 at 1:01 PM that MannKind Corporation Announces Participation at Upcoming Conferences. Leerink Partners Global Biopharma Conference 2024 –
Mannkind Corp [NASDAQ: MNKD] traded at a high on Wednesday, posting a 3.70 gain after which it closed the day’ session at $3.92. The company report on February 27, 2024 at 4:00 PM that MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results:
Mannkind Corp [NASDAQ: MNKD] traded at a high on Monday, posting a 2.68 gain after which it closed the day’ session at $3.45. The company report on January 2, 2024 at 6:05 AM that MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up
© 2024, Powered by Smart TechOne
